Click here for slides on this topic


Glyburide

A type of oral antihyperglycemic agent of the sulfonylurea class that stimulates insulin secretion from the pancreatic beta-cells. It is indicated as an adjunct to diet and exercise to lower blood glucose levels among patients with type 2 diabetes whose hyperglycemia cannot be controlled by diet and exercise alone. Refer to full prescribing information.
The following content matched the glossary term: Glyburide

CompanionSetType2DiabetesMedications

Top

Patient education companion set featuring handouts on DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, and medications used to treat type 2 diabetes (English and Spanish)

Medications Used To Treat Type 2 Diabetes

Top

Patient education handout showing medications used to treat type 2 diabetes and where and how these medications work in the body to lower blood glucose.

Endocrine Society Guideline on Diabetes and Pregnancy - Glycemic Targets & Glucose Management

Top

Diabetes Management Guidelines Endocrine Society Guideline on Diabetes and Pregnancy   Source Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013 98(11) 4227 4249. Available here.Refer to

Medicamentos para el tratamiento de la diabetes tipo 2

Top

Patient education handout showing medications used to treat type 2 diabetes and where and how these medications work in the body to lower blood glucose—in Spanish.

ADA 2016 Type 2 Diabetes Pharmacologic Therapy

Top

Pharmacologic treatment options for type 2 diabetes from the 2016 ADA guidelines

American Diabetes Association (ADA) Nutrition Guidelines for Adults With Diabetes

Top

Diabetes management guidelines for nutrition from the American Diabetes Association (ADA)

European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013 - Studies Question Sulfonylurea Safety

Top

NDEI's coverage of the European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013 from Barcelona, Spain

 

European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013

Top

NDEI's coverage of the European Association for the Study of Diabetes (EASD) 49th Annual Meeting 2013 from Barcelona, Spain

American Diabetes Association (ADA)/American Geriatrics Society (AGS) Guidelines 2012

Top

Diabetes management guidelines for older adults from the American Diabetes Association (ADA)/American Geriatrics Society (AGS) 

β-cell function preservation after 3.5 years of intensive diabetes therapy

Top

Harrison LB, Adams Huet B, Raskin P, Lingvay I. Beta cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care. 2012;35(7):1406-1412. To assess beta-cell function preservation after 3.5 years of intensive therapy with insulin plus metformin (INS group) versus triple oral therapy (TOT group) with metformin, glyburide, and pioglitazone.

1 2 3 4 Next 

Slide Library Results

Search Results for: Glyburide Slides Found: 18
Glyburide Monotherapy: Effect on Plasma Glucose and Insulin Levels
Effect of Orlistat on Weight Loss in Patients With Type 2 Diabetes
Effect of Orlistat on Weight Loss in Patients With Type 2 Diabetes
Effect of Orlistat on Lipids and Glycemic Control in Patients
Glyburide Monotherapy: Effect on Plasma Glucose and Insulin Levels
ADOPT: Cumulative Incidence of Monotherapy Failure at 5 Years
ADOPT: Adverse Events
ADOPT: Achievement of A1C Levels <7%
Alogliptin and Glyburide Combination Therapy: A1C
ADA/AGS 2012 Consensus Report on Diabetes in Older Adults: Recommendations for Care and Treatment (2 of 3)
ADA/Endocrine Society: Minimizing Hypoglycemia Risks in the Elderly
Insulin Sulfonlyrea Added to Metformin CVD Mortality | NDEI
Metformin + Insulin or Sulfonylurea CVD Mortality | NDEI
Metformin + Insulin or Sulfonylurea CVD Mortality Design | NDEI
Diabetes Pregnancy Guidelines Noninsulin Therapy | NDEI
Diabetes Pregnancy Guidelines Postpartum Lactation GDM | NDEI
Reports of Acute Pancreatitis Type 2 Diabetes Drugs | NDEI
AACE 2015 Guidelines Treating Gestational Diabetes GDM PPT | NDEI